✦ LIBER ✦

Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (CereniaTM) for the prevention of emesis and motion sickness in cats

✍ Scribed by M. A. HICKMAN; S. R. COX; S. MAHABIR; C. MISKELL; J. LIN; A. BUNGER; R. B. McCALL

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacokinetics of maropitant, a no

✍ H. A. BENCHAOUI; S. R. COX; R. P. SCHNEIDER; J. F. BOUCHER; R. G. CLEMENCE 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

Efficacy and safety of maropitant, a sel

✍ G. A. CONDER; H. S. SEDLACEK; J. F. BOUCHER; R. G. CLEMENCE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Effect of epidural and intravenous use o

✍ Brittany M Alvillar; Pedro Boscan; Khursheed R Mama; Tatiana H Ferreira; Jonatha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

396 POSTER Effect of oral (PO) casopitan

✍ L. Adams; B. Johnson; J. Bauman; P. Lebowitz; K. Zhang; T. Webb; E. Gartner; R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

777 SAFETY, TOLERABILITYAND PHARMACOKINE

✍ D. Wilbraham; T. Masuda; S. Deacon; T. Kuwayama; S. Vincent 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Single- and multiple-dose safety, tolera

✍ Bell, Joanne; Baird-Bellaire, Susan; Leil, Tarek; Comery, Thomas; Plotka, Anna; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB